Rachel Abrams was appointed by U.S. District Judge Cynthia Rufe to the Avandia PSC (MDL 1871) to the Plaintiffs’ Steering Committee (“PSC”) which consisted of only 12 members nationally. She was appointed by Judge Joseph R. Goodwin of the U.S. District Court for the Southern District of West Virginia to the PSC in all of the TVM litigations (In re: AMS (MDL 2325), Bard (MDL 2187), Coloplast (MDL 2387), Boston Scientific (MDL 2326), Ethicon/Johnson & Johnson (MDL 2327)). She was appointed to the PSC by Judge Cathy Seibel in In Re: Mirena IUD Products Liability Litigation (MDL 2434). She was also appointed by Judge Donovan Frank of the U.S. District Court for the District of Minnesota to the PSC of In Re: Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation (13-MDL-2441).
Ms. Abrams was appointed by Judge Matthew Kennelly of the U.S. District Court for the Northern District of Illinois to the PSC of In Re: Testosterone Replacement Therapy Products Liability Litigation (MDL 2545). She was appointed as Liaison Counsel In re: Viagra (Sildenafil Citrate) Product Liability Litigation (MDL 2691) by Hon. Richard Seeborg of the Northern District of California. Further, after over 70 attorney applications with oral presentations before Judge Orrick, Ms. Abrams was chosen as 1 of 13 attorneys to be on the Juul MDL PSC (MDL-2913).
Most recently, Levin Simes Abrams LLP was appointed co-lead counsel of the Uber and Lyft JCCPs (5188 and 5061, respectively). Ms. Abrams is heavily involved in both Ride Share litigations.
Through all this work, Rachel has developed the knowledge and expertise required to effectively litigate cases. In her numerous roles in consolidated mass tort litigations, she has taken hundreds of depositions, primarily working with experts in various fields. She has prepared and assisted with dozens of trials in both state and federal jurisdictions. Her reputation for working cooperatively with other attorneys is evidenced by her track record in leadership positions in numerous mass tort litigations.
Features and Recognitions
Ms. Abrams has spoken at several seminars and conferences and often lectures in the areas of pharmaceutical/medical device litigation and Ride Share sexual assaults. She was identified as a “Rising Star” by Super Lawyers for six years in a row and then a “Super Lawyer” every year since then.
Rachel Abrams authored an article for Plaintiff Magazine, published in January of 2016, titled “The Pros and Cons of Multi-District Litigation Consolidation.”
Plaintiff Magazine featured Rachel with an in-depth two-page profile in their December 2018 edition: “Rachel Abrams – Would-be marine biologist uses her scientific expertise to litigate against Big Pharma, medical device firms.”